Jeff Spitzner Email & Phone Number

Columbus, OH, US

DNA Nanobots is a platform biotechnology company with IP-based products and services for improved design and delivery of therapeutics including better targeting and larger payloads. Non-viral gene delivery is our top business area. Nanobots are large, folded DNA nanostructures that enable precision control over the number and spatial locations of targeting.

PanoMatrix is developing a novel activated nanocellulose crystal material isolated from the ivory palm nut. This natural material has amazing properties for wound healing and beauty applications.

Jeff Spitzner serves as founder and CEO of MatchTx, a new Big Data healthcare analytics software company with unique patent-pending technology for the medical industry. The solution enables matching patients to cancer drugs and clinical trials with novel methods to find best matches using genetic, clinical, and outcome data. The tech uses Deep Genetic.

Amperand provides services and solutions for Technology Business Development, Tech Startups, and Innovation projects, including:- Technology commercialization and tech start-up consulting including assessments, business strategy, product development roadmaps, business planning, market/competitive analysis, fundraising.- Technology Business Management.

We are developing a Noninvasive Deep Brain Stimulation treatment for many diseases in a very cost effective manner. We use a novel form of Noninvasive Deep Brain Stimulation that can target a region deep inside the brain without stimulating the surrounding areas. The Medical Device is not cleared by the FDA for commercial distribution in the United States.

Better Reporting serves the investment and business communities with agile high quality financial management solutions.

Jeff Spitzner was the business founder of AEIOU Scientific and its CEO from inception through its successful investment fundraising launch and product readiness for scientific sales. The Company was able to prove its scientific instrument in per reviewed publications and achieve FDA Pre-Submission review with only non-dilutive capital. The mission of AEIOU.

Signet Innovations focuses on licensing and commercializing technology and IP from universities and research institutions to create new companies and bring new products to market. Signet Accel is the premiere company in the Innovations portfolio. Signet Innovations is building an active portfolio in strategic sectors and looks for technologies and early.

Ohio Telehealth Initiative (OTI) is a non-profit organization formed to promote and raise awareness for telehealth solutions to improve the quality and efficiency of healthcare while lowering costs and risks and improving patients' experiences. OTI works with leading healthcare organizations in the State of Ohio to study, educate, implement, and train on.

CareMeeting was formed to address a critical problem in healthcare - the need for better communication and collaboration between doctors, patients, family members, and care workers. In particular, CareMeeting provides interactive telehealth tools for patient-centric care. The tools include a distributed cloud platform for concurrent participation including.

Signet Accel provides the collaborative healthcare analytics platform for clinical practice and biomedical and translational research. The Accelematics™ product is a distributed (decentralized) patient disease registry solution that enables each organization (hospitals, research centers, biopharma companies, CRO’s, etc.) to securely share and analyze data.

Signet Ventures is the M&A and investment arm of Signet Enterprises, which includes Signet International, Signet Capital (investment bank, debt financing, financial services), and Signet Development – which provides full service financing, development and management services, and specializes in innovative public-private partnerships. Signet currently.

SoftSyl Technologies is a voice technology software firm specializing in cloud-based IVR (Interactive Voice Response) and call center solutions. SoftSyl developed from the ground up an innovative integrated full-function IVR system built by industry experts, using the leading technologies to be: (1) Standards compliant (VoiceXML); (2) Fast, high.

Dublin, Ohio, US

bioWorld is a global supplier of life sciences and biotechnology lab products for research, including affinity chromatography, molecular biology, cell culture and microbiology. The company was founded in 1994 and is headquartered in Dublin, Ohio. bioWorld is a science-driven company.My role as VP was to develop a strategic business growth plan, lead.

Columbus, Ohio, US

Added chief executive title and role in addition to President and Chief Science Officer. Led successful fundraising efforts and grew customer base to over 100 enterprise sites and 300% increase in sales. Electronic Lab Notebook (ELN) systems were sold to a wide range of pharmaceutical and biotechnology companies, university and non-profit research.

Rescentris develops electronic lab notebook (ELN) software called CERF for the life sciences and general research industries. CERF is built using leading semantic technologies to manage and share scientific information and lab records. Rescentris partnered with The Ohio State University to receive the State's first Third Frontier grant ($6 Million) to.

LabBook developed bioinformatics software, including the Genomic Workspace and the Human Genome Database, and worked to advance the BSML genomics data standard. LabBook worked to develop a desktop environment to deliver content and services to scientists. Technology and products were sold to companies such as Bristol-Myer Squibb, Johnson and Johnson, IBM.

Visual Genomics was a software company that focused on bioinformatics, electronic lab notebooks, and data management solutions for the life sciences research industry. Its founders developed the BSML data standard for genomics in 1997 as the first XML based data standard in life sciences, and the BSML Browser for bioinformatics as one of the first XML.

Commercialized Ph.D. research on DNA Topoisomerase enzymes by developing reagents and kits for drug development and cancer research studies.

Post-Doc, Biology

Ph.D., Molecular Genetics